Horizon Bancorp Inc /In/ Bristol Myers Squibb CO Transaction History

Horizon Bancorp Inc /In/

$216 Million
Q3 2024

A detailed history of Horizon Bancorp Inc /In/ transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Horizon Bancorp Inc /In/ holds 2,163 shares of BMY stock, worth $118,337. This represents 0.05% of its overall portfolio holdings.

Number of Shares

2,163

Previous 2,237 3.31%

Holding current value

$118,337

Previous $93,000 20.43%

% of portfolio

0.05%

Previous 0.04%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	SELL	$39.66 - $51.75 $2,934 - $3,829	-74 Reduced 3.31%	2,163 $112,000
Q2 2024 Jul 24, 2024	BUY	$40.25 - $52.99 $14,087 - $18,546	350 Added 18.55%	2,237 $93,000
Q1 2024 Apr 19, 2024	BUY	$47.98 - $54.4 $4,126 - $4,678	86 Added 4.78%	1,887 $102,000
Q4 2023 Jan 16, 2024	BUY	$48.48 - $57.85 $3,781 - $4,512	78 Added 4.53%	1,801 $92,000
Q3 2023 Oct 24, 2023	BUY	$57.89 - $64.73 $83,535 - $93,405	1,443 Added 515.36%	1,723 $100,000
Q2 2023 Aug 03, 2023	BUY	$63.71 - $70.74 $17,838 - $19,807	280 New	280 $18,000
Q4 2022 Feb 09, 2023	SELL	$68.48 - $81.09 $702,947 - $832,388	-10,265 Reduced 72.47%	3,900 $281,000
Q3 2020 Nov 12, 2020	BUY	$57.43 - $63.64 $3,962 - $4,391	69 Added 0.49%	14,165 $854,000
Q2 2020 Aug 10, 2020	SELL	$54.82 - $64.09 $50,544 - $59,090	-922 Reduced 6.14%	14,096 $829,000
Q1 2020 Apr 20, 2020	SELL	$46.4 - $67.43 $327,444 - $475,853	-7,057 Reduced 31.97%	15,018 $837,000
Q4 2019 Feb 11, 2020	BUY	$49.21 - $64.19 $1.09 Million - $1.42 Million	22,075 New	22,075 $1.42 Million

Others Institutions Holding BMY

# of Institutions

2,468

Shares Held

1.5B

Call Options Held

29.6M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $116B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Horizon Bancorp Inc /In/, based on Form 13F filings with the SEC.

News

Stay updated on Horizon Bancorp Inc /In/ with notifications on news.

Account

Horizon Bancorp Inc /In/ Bristol Myers Squibb CO Transaction History